Review article · 2024 · Open access

Microglia, Trem2, and Neurodegeneration

Qian Shi, Raul A. Gutierrez, Manzoor A. Bhat

The Neuroscientist, 31(2), 159–176 · Published 20 May 2024 · DOI 10.1177/10738584241254118

Open full textCite this paper

In brief

“Microglia, Trem2, and Neurodegeneration” is a 2024 review article by Qian Shi and 2 co-authors, published in The Neuroscientist. OpenAlex counts 84 citations as of 20 November 2026, which puts it in the top 3% of works published in 2024 by citations. It is open access under a CC BY-NC licence: the full text is free to read at The Neuroscientist.

Citations
84
Most cited in
2026 (48)
Field-weighted impact
3.35
References
121
Authors
3

Abstract

Microglia are a specialized type of neuroimmune cells that undergo morphological and molecular changes through multiple signaling pathways in response to pathological protein aggregates, neuronal death, tissue injury, or infections. Microglia express Trem2, which serves as a receptor for a multitude of ligands enhancing their phagocytic activity. Trem2 has emerged as a critical modulator of microglial activity, especially in many neurodegenerative disorders. Human TREM2 mutations are associated with an increased risk of developing Alzheimer disease (AD) and other neurodegenerative diseases. Trem2 plays dual roles in neuroinflammation and more specifically in disease-associated microglia. Most recent developments on the molecular mechanisms of Trem2, emphasizing its role in uptake and clearance of amyloid β (Aβ) aggregates and other tissue debris to help protect and preserve the brain, are encouraging. Although Trem2 normally stimulates defense mechanisms, its dysregulation can intensify inflammation, which poses major therapeutic challenges. Recent therapeutic approaches targeting Trem2 via agonistic antibodies and gene therapy methodologies present possible avenues for reducing the burden of neurodegenerative diseases. This review highlights the promise of Trem2 as a therapeutic target, especially for Aβ-associated AD, and calls for more mechanistic investigations to understand the context-specific role of microglial Trem2 in developing effective therapies against neurodegenerative diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2024). Microglia, Trem2, and Neurodegeneration. The Neuroscientist, 31(2), 159–176. https://doi.org/10.1177/10738584241254118

MLA 9

Shi, Qian, et al. “Microglia, Trem2, and Neurodegeneration.” The Neuroscientist, vol. 31, no. 2, 2024, pp. 159–176. https://doi.org/10.1177/10738584241254118.

Chicago

Shi, Qian, Raul A. Gutierrez, and Manzoor A. Bhat. 2024. “Microglia, Trem2, and Neurodegeneration.” The Neuroscientist 31 (2): 159–176. https://doi.org/10.1177/10738584241254118.

Harvard

Shi, Q., Gutierrez, R. A. and Bhat, M. A. (2024) ‘Microglia, Trem2, and Neurodegeneration’, The Neuroscientist, 31(2), pp. 159–176. doi:10.1177/10738584241254118.

IEEE

Q. Shi, R. A. Gutierrez, and M. A. Bhat, “Microglia, Trem2, and Neurodegeneration,” The Neuroscientist, vol. 31, no. 2, pp. 159–176, 2024, doi: 10.1177/10738584241254118.

BibTeX

@article{shi2024microglia,
  title     = {{Microglia, Trem2, and Neurodegeneration}},
  author    = {Shi, Qian and Gutierrez, Raul A. and Bhat, Manzoor A.},
  journal   = {The Neuroscientist},
  year      = {2024},
  volume    = {31},
  number    = {2},
  pages     = {159--176},
  doi       = {10.1177/10738584241254118},
  url       = {https://doi.org/10.1177/10738584241254118}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202455
20253131
20264848

Its field-weighted citation impact is 3.35: it has been cited 3.35 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • microglia
  • TREM2
  • neurodegeneration
  • Alzheimer's disease
  • amyloid-beta clearance
  • neuroinflammation
  • disease-associated microglia
  • agonistic antibodies

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2024). Microglia, Trem2, and Neurodegeneration. The Neuroscientist, 31(2), 159–176. https://doi.org/10.1177/10738584241254118

How many times has this paper been cited?

84 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Neuroscientist: sign in and open the full text from this page.

Who wrote this paper?

Qian Shi, Raul A. Gutierrez, Manzoor A. Bhat.

What is the DOI of this paper?

10.1177/10738584241254118, permanently at https://doi.org/10.1177/10738584241254118. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.